Macrogenics Inc (NAS:MGNX)
$ 4.36 0.25 (6.07%) Market Cap: 273.08 Mil Enterprise Value: 122.86 Mil PE Ratio: 0 PB Ratio: 2.57 GF Score: 60/100

MacroGenics Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 03:30PM GMT
Release Date Price: $10.3 (-5.07%)
Alex Kramer J.P. Morgan;Analyst

Good morning and welcome to the thursday morning session of the 42nd Annual JPMorgan Healthcare Conference. My name is Alex Kramer, and I am an associate on the Healthcare Investment Banking team at JP Morgan.

Today is my pleasure to introduce our next presenting company, MacroGenics and our presenter today, Scott Koenig, CEO of the company. The format today will be a 20-minute corporate presentation followed by Q&A. And with that, Scott the floor is yours.

Scott Koenig MacroGenics
Inc - CEO

Thank you Alex, and thank you very much for the invitation to present at the JPMorgan conference.

I'll be making forward-looking statements during the course of this presentation. So please refer to our SEC filings to understand the risks associated with the investment in MacroGenics.

So 2024 looks to be a very exciting year in MacroGenics. In 2023, we built on the successes of our preclinical and clinical portfolio and significantly advance our cash runway, since the inception of the company we've

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot